Latest oppositions filed by Zentiva K.s.

This table presents recent patent oppositions filed by Zentiva K.s. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM INTERNATIONAL GMBHOct 14, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 13, 2024
EP3626270New UseNOVARTIS AGJul 11, 2024
EP2981255Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM INTERNATIONAL GMBHJun 13, 2023
EP2959894S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS AGOct 12, 2022
EP2653873Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MA INC.Sep 23, 2022
EP3725778Formulations Of EnzalutamideASTELLAS PHARMA INC.May 13, 2022
EP3053580Method Of Providing Pirfenidone Therapy To A PatientINTERMUNE, INC.Mar 30, 2022
EP2234617Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA NVDec 31, 2021
EP2478907Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY, INC.Jun 2, 2021